Production (Stage)
aTyr Pharma, Inc.
ATYR
$3.75
-$0.05-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.35M | 72.13M | 65.99M | 78.48M | 84.50M |
| Total Receivables | 988.00K | 1.74M | 1.83M | 1.63M | 2.48M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.93M | 8.09M | 8.50M | 10.19M | 9.94M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 83.27M | 81.95M | 76.32M | 90.30M | 96.92M |
|
|
|||||
| Total Current Assets | 83.27M | 81.95M | 76.32M | 90.30M | 96.92M |
| Net Property, Plant & Equipment | 11.48M | 11.86M | 12.24M | 12.62M | 12.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.50M | 3.02M | 3.06M | 3.03M | 3.34M |
| Total Assets | 97.25M | 96.83M | 91.62M | 105.94M | 113.25M |
|
|
|||||
| Total Accounts Payable | 1.53M | 4.32M | 3.95M | 1.26M | 4.89M |
| Total Accrued Expenses | 7.86M | 9.39M | 8.96M | 9.41M | 9.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.29M | 1.25M | 1.21M | 1.17M | 1.14M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.68M | 14.97M | 14.12M | 11.84M | 15.98M |
|
|
|||||
| Total Current Liabilities | 10.68M | 14.97M | 14.12M | 11.84M | 15.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.70M | 12.03M | 12.36M | 12.68M | 12.99M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.38M | 27.00M | 26.48M | 24.52M | 28.97M |
|
|
|||||
| Common Stock & APIC | 622.04M | 602.11M | 582.37M | 581.60M | 568.14M |
| Retained Earnings | -546.93M | -532.05M | -517.08M | -499.82M | -483.51M |
| Treasury Stock & Other | -66.00K | -40.00K | 36.00K | -168.00K | -158.00K |
| Total Common Equity | 75.05M | 70.02M | 65.33M | 81.61M | 84.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 75.05M | 70.02M | 65.33M | 81.61M | 84.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -188.00K | -187.00K | -186.00K | -184.00K | -184.00K |
| Total Equity | 74.86M | 69.83M | 65.14M | 81.42M | 84.28M |
|
|
|||||